Kimberly-Clark to buy Kenvue in $48.7 billion deal
Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion,...
Read moreKimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion,...
Read morePerth, Australia (ABN Newswire) – Locksley Resources Limited (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) announced the receipt of a Letter of Interest (‘LOI’)...
Read moreInvestor Insight Executing a well-defined project development strategy for its lithium assets and advancing Direct Lithium Extraction (DLE), CleanTech Lithium...
Read moreLocksley Resources Limited (ASX: LKY, OTCQX: LKYRF, FSE: X5L) (“Locksley” or the “Company”), advises that the Company will host an...
Read moreSarama Resources Ltd. (“Sarama” or the “Company”) (TSX-V:SWA, ASX:SRR) announces that it has filed its written Memorial (the “Memorial”) detailing...
Read more